医療用アイソトープの世界市場レポート 2025

医療用アイソトープ市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.8％で99億2,000万米ドルに成長します。予測期間の成長は、公衆衛生への取り組み、パートナーシップやコラボレーション、インフラへの投資、個別化医療へのシフト、高齢者人口の増加、規制の変更、標準化などに起因すると考えられます。予測期間における主な動向としては、放射性医薬品の成長、サイクロトロンおよびジェネレーター技術の採用、サプライチェーンの強靭性への注力、人工知能（AI）の統合、陽電子放射断層撮影（PET）イメージングの進歩などが挙げられます。

がんと心臓病の発生率の増加は、今後数年間の医療用アイソトープ市場の成長を促進すると予想されます。これらの疾病発生率は、特定期間における集団内の新規症例発生頻度や有病率を意味し、公衆衛生の動向や予防措置の有効性に関する洞察を提供します。がんと心臓病の有病率の増加は、現代技術やデスクワーク中心の職業によって推進される座りがちなライフスタイルの蔓延と関連しており、その結果、身体活動レベルが低下しています。がんや心臓病の診断と治療には、陽電子放射断層撮影法（PET）や単一光子放射断層撮影法（SPECT）などの画像診断技術や、放射線療法、放射性ステントなどの治療法が欠かせないです。例えば、スイスに本部を置く政府間機関である世界保健機関（WHO）によると、2050年までに新たに発生するがん患者数は3,500万人を超えると予測されており、2022年の推定患者数2,000万人と比べて77％の増加となっています。さらに、英国を拠点とする心臓血管研究の慈善団体である英国心臓財団のデータによると、2024年9月現在、英国では約760万人が心臓・循環器系疾患に罹患しており、そのうち約400万人が男性、約360万人が女性です。これらの病気は英国における全死亡者の約27％を占め、年間17万人以上、1日あたり約480人、3分に1人が死亡していることになります。このように、がんと心臓病の罹患率の上昇が、医療用アイソトープ市場の成長に拍車をかけています。

医療用アイソトープ市場の主要企業は、競争力を強化するために戦略的提携に力を入れるようになっています。戦略的提携とは、2つ以上の当事者が特定の相互に有益な目的を共同で追求するための正式な合意です。例えば、2023年9月、米国の医療技術企業であるインターナショナル・アイソトープス社は、米国のバイオメディカルハードウェア企業であるファンテックメディカル社と提携し、両社の顧客向けソリューションを統合しました。この提携は、メディカルイメージングとセラノスティクスの分野に合わせた革新的な密封線源を開発、製造、販売することにより、前臨床イメージング用の校正および参照線源市場を変革することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医療用アイソトープ PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の医療用アイソトープ市場：成長率分析
• 世界の医療用アイソトープ市場の実績：規模と成長, 2019-2024
• 世界の医療用アイソトープ市場の予測：規模と成長, 2024-2029, 2034F
• 世界医療用アイソトープ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医療用アイソトープ市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 安定同位体
• 放射性同位元素
• 世界の医療用アイソトープ市場製造方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 中性子放射化
• サイクロトロン
• 原子炉
• その他の製造方法
• 世界の医療用アイソトープ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 核医学治療
• 機器放射性源
• 診断
• 世界の医療用アイソトープ市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• 調査機関
• 世界の医療用アイソトープ市場安定同位体のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 炭素13
• 窒素15
• 酸素18
• その他の安定同位体
• 世界の医療用アイソトープ市場、放射性同位元素の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• テクネチウム99m
• ヨウ素131
• コバルト60
• ストロンチウム89
• その他の放射性同位元素

第7章 地域別・国別分析

• 世界の医療用アイソトープ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医療用アイソトープ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医療用アイソトープ市場：競合情勢
• 医療用アイソトープ市場：企業プロファイル
  • Rosatom State Atomic Energy Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • GE HealthCare Overview, Products and Services, Strategy and Financial Analysis
  • Urenco Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lantheus Holdings Inc.
• Curium Pharma
• Canadian Nuclear Laboratories
• Eckert & Ziegler Strahlen-und Medizintechnik AG.
• Advanced Accelerator Applications a Novartis company
• Nordion Inc.
• NTP Radioisotopes SOC Ltd.
• The Institute for Radioelements（IRE）
• NorthStar Medical Radioisotopes LLC
• Isotopen Technologien Munchen AG（ITM）
• EczacIbasI-Monrol Nuclear Products Co.
• SHINE Medical Technologies LLC
• Blue Earth Diagnostics Limited
• Isologic Innovative Radiopharmaceuticals
• IBA Radiopharma Solutions

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医療用アイソトープ市場2029：新たな機会を提供する国
• 医療用アイソトープ市場2029：新たな機会を提供するセグメント
• 医療用アイソトープ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Medical isotopes are radioisotopes utilized in medicine, emitting positrons or gamma rays for diagnostic purposes. These isotopes aid in visualizing and targeting specific tissues or abnormalities within the body, facilitating tasks such as evaluating heart function, assessing blood flow to the heart muscle, and diagnosing coronary artery disease.

The main product types of medical isotopes comprise stable isotopes and radioisotopes. Stable isotopes are versions of chemical elements that do not decay over time, retaining their atomic structure indefinitely. Production methods for medical isotopes include neutron activation, cyclotrons, nuclear reactors, and others. These isotopes find applications in nuclear therapy, equipment radioactive sources, and diagnostic procedures. End users of medical isotopes include hospitals, diagnostic centers, and research institutes.

The medical isotopes market research report is one of a series of new reports from The Business Research Company that provides medical isotopes market statistics, including the medical isotopes industry global market size, regional shares, competitors with the medical isotopes market share, detailed medical isotopes market segments, market trends, and opportunities, and any further data you may need to thrive in the medical isotopes industry. These medical isotopes market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical isotopes market size has grown strongly in recent years. It will grow from $6.8 billion in 2024 to $7.35 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the rising incidence of chronic diseases, expansion of the pharmaceutical industry, advancements in cancer treatment, demand for diagnostic imaging, and advancements in nuclear medicine.

The medical isotopes market size is expected to see strong growth in the next few years. It will grow to $9.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to public health initiatives, partnerships and collaborations, investment in infrastructure, a shift towards personalized medicine, a growing geriatric population, regulatory changes, and standards. Major trends in the forecast period include growth in radiopharmaceuticals, adoption of cyclotron and generator technologies, focus on supply chain resilience, integration of artificial intelligence (AI), and advancements in positron emission tomography (PET) imaging.

The increasing rates of cancer and heart disease are expected to drive the growth of the medical isotope market in the coming years. These rates refer to the frequency of new cases and the prevalence of these diseases within a population over a specific period, offering insights into public health trends and the effectiveness of preventive measures. The growing prevalence of cancer and heart disease is linked to the widespread sedentary lifestyle promoted by modern technology and desk-based occupations, which result in lower physical activity levels. Medical isotopes are crucial in diagnosing and treating cancer and heart disease, utilizing imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans, as well as therapies like radiation therapy and radioactive stents. For instance, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, by 2050, the number of new cancer cases is projected to exceed 35 million, representing a 77% increase compared to the estimated 20 million cases in 2022. Additionally, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that as of September 2024, approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women living with these conditions. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or roughly 480 deaths per day, equivalent to one death every three minutes. Thus, the rising incidence of cancer and heart disease is fueling the growth of the medical isotope market.

Leading companies in the medical isotope market are increasingly focusing on strategic collaborations to enhance their competitive positioning. A strategic collaboration is a formal agreement between two or more parties to jointly pursue specific, mutually beneficial objectives. For example, in September 2023, International Isotopes Inc., a U.S.-based medical technology company, partnered with Phantech Medical, a U.S.-based biomedical hardware company, to integrate their solutions for customers. This partnership aims to transform the calibration and reference sources market for pre-clinical imaging by developing, producing, and distributing innovative sealed sources tailored for the medical imaging and theranostics sectors.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biopharmaceutical company, acquired ARTMS Inc. for an undisclosed sum. This acquisition equips Telix with enhanced access to ARTMS' innovative radiopharmaceutical production technologies, fortifying its position in the development and commercialization of targeted radiopharmaceuticals for cancer imaging and therapy. ARTMS Inc., headquartered in Canada, specializes in the development of technology that revolutionizes the production of diagnostic imaging isotopes.

Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien Munchen AG (ITM), EczacIbasI-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotop, Coqui RadioPharmaceuticals Corp., Jubilant DraxImage Inc., Positron Corporation

North America was the largest region in the medical isotopes market in 2024. The regions covered in the medical isotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical isotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical isotopes market consists of sales of technetium-99m, carbon-11, and gallium-68 which serve specific purposes in medical diagnosis and therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Isotopes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical isotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical isotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical isotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Stable Isotopes; Radio Isotopes
• 2) By Production Method: Neutron Activation; Cyclotron; Nuclear Reactor; Other Production Method
• 3) By Application: Nuclear Therapy; Equipment Radioactive Source; Diagnosis
• 4) By End Use: Hospitals; Diagnostic Centers; Research Institutes
• Subsegments:
• 1) By Stable Isotopes: Carbon-13; Nitrogen-15; Oxygen-18; Other Stable Isotopes
• 2) By Radio Isotopes: Technetium-99m; Iodine-131; Cobalt-60; Strontium-89; Other Radio Isotopes
• Companies Mentioned: Rosatom State Atomic Energy Corporation; Bayer AG; Siemens Healthineers AG; GE HealthCare; Urenco Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Isotopes Market Characteristics

3. Medical Isotopes Market Trends And Strategies

4. Medical Isotopes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Medical Isotopes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Medical Isotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Medical Isotopes Market Growth Rate Analysis
• 5.4. Global Medical Isotopes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Medical Isotopes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Medical Isotopes Total Addressable Market (TAM)

6. Medical Isotopes Market Segmentation

• 6.1. Global Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stable Isotopes
• Radio Isotopes
• 6.2. Global Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neutron Activation
• Cyclotron
• Nuclear Reactor
• Other Production Method
• 6.3. Global Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nuclear Therapy
• Equipment Radioactive Source
• Diagnosis
• 6.4. Global Medical Isotopes Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Research Institutes
• 6.5. Global Medical Isotopes Market, Sub-Segmentation Of Stable Isotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbon-13
• Nitrogen-15
• Oxygen-18
• Other Stable Isotopes
• 6.6. Global Medical Isotopes Market, Sub-Segmentation Of Radio Isotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Technetium-99m
• Iodine-131
• Cobalt-60
• Strontium-89
• Other Radio Isotopes

7. Medical Isotopes Market Regional And Country Analysis

• 7.1. Global Medical Isotopes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Medical Isotopes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Isotopes Market

• 8.1. Asia-Pacific Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Isotopes Market

• 9.1. China Medical Isotopes Market Overview
• 9.2. China Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Isotopes Market

• 10.1. India Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Isotopes Market

• 11.1. Japan Medical Isotopes Market Overview
• 11.2. Japan Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Isotopes Market

• 12.1. Australia Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Isotopes Market

• 13.1. Indonesia Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Isotopes Market

• 14.1. South Korea Medical Isotopes Market Overview
• 14.2. South Korea Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Isotopes Market

• 15.1. Western Europe Medical Isotopes Market Overview
• 15.2. Western Europe Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Isotopes Market

• 16.1. UK Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Isotopes Market

• 17.1. Germany Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Isotopes Market

• 18.1. France Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Isotopes Market

• 19.1. Italy Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Isotopes Market

• 20.1. Spain Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Isotopes Market

• 21.1. Eastern Europe Medical Isotopes Market Overview
• 21.2. Eastern Europe Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Isotopes Market

• 22.1. Russia Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Isotopes Market

• 23.1. North America Medical Isotopes Market Overview
• 23.2. North America Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Isotopes Market

• 24.1. USA Medical Isotopes Market Overview
• 24.2. USA Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Isotopes Market

• 25.1. Canada Medical Isotopes Market Overview
• 25.2. Canada Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Isotopes Market

• 26.1. South America Medical Isotopes Market Overview
• 26.2. South America Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Isotopes Market

• 27.1. Brazil Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Isotopes Market

• 28.1. Middle East Medical Isotopes Market Overview
• 28.2. Middle East Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Isotopes Market

• 29.1. Africa Medical Isotopes Market Overview
• 29.2. Africa Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Isotopes Market Competitive Landscape And Company Profiles

• 30.1. Medical Isotopes Market Competitive Landscape
• 30.2. Medical Isotopes Market Company Profiles
  • 30.2.1. Rosatom State Atomic Energy Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE HealthCare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Urenco Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Isotopes Market Other Major And Innovative Companies

• 31.1. Lantheus Holdings Inc.
• 31.2. Curium Pharma
• 31.3. Canadian Nuclear Laboratories
• 31.4. Eckert & Ziegler Strahlen- und Medizintechnik AG.
• 31.5. Advanced Accelerator Applications a Novartis company
• 31.6. Nordion Inc.
• 31.7. NTP Radioisotopes SOC Ltd.
• 31.8. The Institute for Radioelements (IRE)
• 31.9. NorthStar Medical Radioisotopes LLC
• 31.10. Isotopen Technologien Munchen AG (ITM)
• 31.11. EczacIbasI-Monrol Nuclear Products Co.
• 31.12. SHINE Medical Technologies LLC
• 31.13. Blue Earth Diagnostics Limited
• 31.14. Isologic Innovative Radiopharmaceuticals
• 31.15. IBA Radiopharma Solutions

32. Global Medical Isotopes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Isotopes Market

34. Recent Developments In The Medical Isotopes Market

35. Medical Isotopes Market High Potential Countries, Segments and Strategies

• 35.1 Medical Isotopes Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Medical Isotopes Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Medical Isotopes Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer